Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 58Breast Neoplasms 54Ovarian Neoplasms 34Triple Negative Breast Neoplasms 28Endometrial Neoplasms 25Lung Neoplasms 24Fallopian Tube Neoplasms 23Neoplasm Metastasis 22Parkinson Disease 4, Autosomal Dominant Lewy Body 20Squamous Cell Carcinoma of Head and Neck 19Neoplasms 14Esophageal Neoplasms 13Esophageal Squamous Cell Carcinoma 12Carcinoma, Ovarian Epithelial 10Stomach Neoplasms 9Head and Neck Neoplasms 8Colorectal Neoplasms 8Carcinoma 8Adenocarcinoma Of Esophagus 7Peritoneal Neoplasms 6Adenocarcinoma 6Uterine Cervical Neoplasms 5Melanoma 5Small Cell Lung Carcinoma 4Oropharyngeal Neoplasms 4Cholangiocarcinoma 4Carcinoma, Transitional Cell 4Urinary Bladder Neoplasms 3Recurrence 3Pancreatic Neoplasms 3

Interventions

pembrolizumab 1Vinorelbine 1Surveys and Questionnaires 1Radiotherapy 1Pemetrexed 1Paclitaxel 1Observation 1Nivolumab 1Hypnosis 1Health Records, Personal 1Gemcitabine 1Dexamethasone 1Carboplatin 1Bevacizumab 1Adrenal Cortex Hormones 1Acetylcysteine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lung Diseases, Interstitial × Paclitaxel × 90 days × Clear all
NCT07420439 2026-04-27

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Intergroupe Francophone de Cancerologie Thoracique

Phase 2 Not yet recruiting
108 enrolled

Lung Diseases, Interstitial

Data powered by HemOnc (CC BY 4.0) Colophon âš¡